The recommended plateau pressure and tidal volume goals in ARDS

Explain how PRVC works

A potential cause of a peak inspiratory pressure of 52 and a plateau pressure of 19

These two things improve mortality in ARDS

A patient with asthma exacerbation is intubated. ABG shows respiratory acidosis. RR is set to 25, TV 450. The patient becomes hypotensive with this waveform. This is the next best step with the ventilator.

This is the first line vasopressor in septic shock

This is the first-line vasopressor in cardiogenic shock

This vasopressor has been shown to be definitively inferior because of tachyarrhythmias and possible increased mortality

Inopressor that causes lactic acidosis

The best treatment for peripherally extravasated norepinephrine

Hypotensive elderly man with low hgb and no signs of bleeding

The name of this sign

The location of abnormal fluid

The name of this sign

The potentially life-threatening finding here

5 drugs that cover MRSA

4 drugs that cover Pseudomonas

Physical examination that needs to be performed for candidemic patients

This side effect from cefepime is more likely in patients with renal dysfunction

Pulmonary toxicity of daptomycin

The NICE SUGAR trial showed that targeting this BG level resulted in lower mortality

The ProMISe ProCESS, and ARISE trials are three multicentered large RCTs that showed this sepsis treatment does not improve mortality

The PROSEVA trial showed that proning patients with ARDS and this P/F ratio improves outcomes

The TRAIN trial showed that this transfusion threshold in acute brain injury improves functional neurological status at 180 days

The DanGer SHOCK trial is the only large, multicentered RCT thus far that has shown improved mortality in cardiogenic shock. This was the intervention and main inclusion criteria (patient population)